Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li Di

Showing results (211-220 of 293) with videos related to

Pageof 30
Sort By:
Medicine|February 10, 2025
Salivary duct carcinoma presenting with unilateral multiple cranial nerve lesions and concurrent intracranial metastasis: A case reportBo Zhu, Qing-Zi Zhang, Kun Guo, et al.
The Journal of Investigative Dermatology|November 10, 2019
Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome KeratinocytesMing Yang Lee, Hong-Zhan Wang, Thomas W White, et al.
Annals of Neurology|November 24, 2025
Effects of Thymectomy in Late-Onset Myasthenia Gravis: A Multi-Center Longitudinal Retrospective StudyJiaxin Chen, Chunhua Su, Li Feng, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2011
Pyrrolidin-3-yl-N-methylbenzamides as potent histamine 3 receptor antagonistsDahui Zhou, Jonathan L Gross, Jean Y Sze, et al.
Drug Discovery Today|April 18, 2012
Evidence-based approach to assess passive diffusion and carrier-mediated drug transportLi Di, Per Artursson, Alex Avdeef, et al.
Molecular Pharmaceutics|April 12, 2012
pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discoveryManthena V Varma, Iain Gardner, Stefanus J Steyn, et al.
Therapeutic Advances in Neurological Disorders|January 13, 2025
Short-term and long-term prognoses in AChR-Ab positive very-late-onset myasthenia gravis patientsNairong Xie, Qing Liu, Qi Wen, et al.
Physiology & Behavior|March 20, 2016
Exendin-4, a glucagon-like peptide 1 receptor agonist, protects against amyloid-β peptide-induced impairment of spatial learning and memory in ratsXiao-Tao Jia, Ye-Tian, Yuan-Li, et al.
Human Gene Therapy. Clinical Development|October 22, 2013
Phase I study protocol for ex-vivo lentiviral gene therapy for the inherited skin disease, Netherton SyndromeWei-Li Di, Jemima E Mellerio, Catina Bernadis, et al.
Frontiers in Genetics|December 6, 2021
Missense Mutations of Codon 116 in the <i>SOD1</i> Gene Cause Rapid Progressive Familial ALS and Predict Short Viability With PMA PhenotypeXinmei Wen, Wenjia Zhu, Nan L Xia, et al.
Pageof 30

Showing results (211-220 of 293) with videos related to

Sort By:
Pageof 30
Medicine|February 10, 2025
Salivary duct carcinoma presenting with unilateral multiple cranial nerve lesions and concurrent intracranial metastasis: A case reportBo Zhu, Qing-Zi Zhang, Kun Guo, et al.
The Journal of Investigative Dermatology|November 10, 2019
Allele-Specific Small Interfering RNA Corrects Aberrant Cellular Phenotype in Keratitis-Ichthyosis-Deafness Syndrome KeratinocytesMing Yang Lee, Hong-Zhan Wang, Thomas W White, et al.
Annals of Neurology|November 24, 2025
Effects of Thymectomy in Late-Onset Myasthenia Gravis: A Multi-Center Longitudinal Retrospective StudyJiaxin Chen, Chunhua Su, Li Feng, et al.
Bioorganic & Medicinal Chemistry Letters|August 17, 2011
Pyrrolidin-3-yl-N-methylbenzamides as potent histamine 3 receptor antagonistsDahui Zhou, Jonathan L Gross, Jean Y Sze, et al.
Drug Discovery Today|April 18, 2012
Evidence-based approach to assess passive diffusion and carrier-mediated drug transportLi Di, Per Artursson, Alex Avdeef, et al.
Molecular Pharmaceutics|April 12, 2012
pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discoveryManthena V Varma, Iain Gardner, Stefanus J Steyn, et al.
Therapeutic Advances in Neurological Disorders|January 13, 2025
Short-term and long-term prognoses in AChR-Ab positive very-late-onset myasthenia gravis patientsNairong Xie, Qing Liu, Qi Wen, et al.
Physiology & Behavior|March 20, 2016
Exendin-4, a glucagon-like peptide 1 receptor agonist, protects against amyloid-β peptide-induced impairment of spatial learning and memory in ratsXiao-Tao Jia, Ye-Tian, Yuan-Li, et al.
Human Gene Therapy. Clinical Development|October 22, 2013
Phase I study protocol for ex-vivo lentiviral gene therapy for the inherited skin disease, Netherton SyndromeWei-Li Di, Jemima E Mellerio, Catina Bernadis, et al.
Frontiers in Genetics|December 6, 2021
Missense Mutations of Codon 116 in the <i>SOD1</i> Gene Cause Rapid Progressive Familial ALS and Predict Short Viability With PMA PhenotypeXinmei Wen, Wenjia Zhu, Nan L Xia, et al.
Pageof 30